Table 3 Summary of enrolled subjects
From: Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease
PD (n = 17) | Controls (n = 15) | |
|---|---|---|
Age ± SD (years) | 54.5 ± 9.2 | 59.9 ± 10.2 |
Male % | 67 | 41 |
PD duration ± SD (years) | 6 ± 4 | |
Medications | ||
Unmedicated | 2 | |
L-DOPA | 3 | 2 |
DA agonists | 1 | |
L-DOPA + DA agonists | 8 |
